Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Haleon PLC ( (GB:HLN) ) is now available.
Haleon PLC announced that as of June 30, 2025, it has issued a total of 8,988,533,553 ordinary shares, with 3,880,205 held as treasury shares. This results in 8,984,653,348 shares having voting rights, a key figure for shareholders and stakeholders to determine their notification obligations under the FCA’s Disclosure Guidance and Transparency Rules. This update is crucial for maintaining transparency and ensuring stakeholders are informed about their voting rights and obligations.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Neutral.
Haleon PLC’s overall stock score reflects strong financial performance and positive earnings call outlook. Despite some bearish technical indicators and valuation concerns, the company’s strategic initiatives in growth markets and its commitment to shareholder returns provide a positive long-term outlook. Challenges such as market headwinds and inventory adjustments are notable risks.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a diverse product portfolio across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.
Average Trading Volume: 25,463,863
Technical Sentiment Signal: Buy
Current Market Cap: £33.99B
Learn more about HLN stock on TipRanks’ Stock Analysis page.